Literature DB >> 7603808

Invasive group B streptococcal disease in children beyond early infancy.

S M Hussain1, G S Luedtke, C J Baker, P M Schlievert, R J Leggiadro.   

Abstract

There is little information available on invasive group B Streptococcus (GBS) infection in pediatric patients older than 3 months of age. Review of infection control records at LeBonheur Children's Medical Center from January 1, 1986, to June 30, 1993, identified 143 patients with a positive GBS culture from normally sterile body fluid. Medical records of 18 (13%) patients > 3 months old with their first GBS infection were reviewed. Age range was 15 weeks to 18 years (median age, 13 months). Ten were black and 11 were girls. Five infants had a history of premature birth and 2 infants were infected with human immunodeficiency virus. The serotype distribution of 12 available GBS isolates was 4 type III, 2 each type V and Ia and 1 each type Ia/c, Ib/c, II and II/c. Bacteremia without a focus (9 patients) was the most common clinical manifestation. All 4 type III isolates were associated with bacteremia. One infant with human immunodeficiency virus infection had sepsis and bullous desquamation; a toxin-producing type V strain was isolated from her blood. Two adolescents with ventriculoperitoneal shunts had meningitis, including one whose cerebrospinal fluid also grew a type V strain. Other clinical manifestations were septic arthritis, endocarditis (Ia, II/c), central venous catheter (Ia/c) and ventriculostomy infections.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7603808     DOI: 10.1097/00006454-199504000-00006

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  17 in total

1.  Simultaneous occurrence of group B Streptococcus and echovirus 20.

Authors:  M L Dronkert; A G Ketel; R de Groot
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

2.  Very late onset infections in the neonatal intensive care unit.

Authors:  James L Wynn; Daniel K Benjamin; Daniel K Benjamin; Michael Cohen-Wolkowiez; Reese H Clark; P Brian Smith
Journal:  Early Hum Dev       Date:  2011-09-15       Impact factor: 2.079

3.  Group B streptococcal meningitis in infants beyond the neonatal period.

Authors:  Shalini Dwivedi; Bimal K Das; Satinder Aneja; Suvasini Sharma; Mona K Chaturvedi; Geoff Kahn; Sean P Fitzwater; Aruna Chandran; Nitya Wadhwa; Shinjini Bhatnagar
Journal:  Indian J Pediatr       Date:  2013-07-24       Impact factor: 1.967

4.  Survival of group B streptococcus type III in mononuclear phagocytes: differential regulation of bacterial killing in cord macrophages by human recombinant gamma interferon and granulocyte-macrophage colony-stimulating factor.

Authors:  L Maródi; R Káposzta; E Nemes
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 5.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 6.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

7.  Late and very late onset group B Streptococcus sepsis: one and the same?

Authors:  Joseph B Cantey; Courtney Baldridge; Rachel Jamison; Leticia A Shanley
Journal:  World J Pediatr       Date:  2014-01-25       Impact factor: 2.764

8.  Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type.

Authors:  J A Elliott; K D Farmer; R R Facklam
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

Review 9.  Group B streptococcal meningitis in a 5-year-old boy.

Authors:  Sanjeev Managoli; Pushpa Chaturvedi; Krishna Y Vilhekar
Journal:  Indian J Pediatr       Date:  2003-06       Impact factor: 1.967

10.  Group B streptococcus meningitis in a child with cochlear implant.

Authors:  Daniel Glikman; Michal Luntz; Rabia Shihada; Zeev Zonis; Lea Even
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.